Risks and benefits of hormone replacement therapy in reproductive age women after hematopoietic stem cell transplants: a narrative review

Introduction and aims of the study: Haematopoietic stem cell transplantation increases survival for hematologic malignancies, but increasing numbers of survivors struggle with the side effects. For women with established primary ovarian failure, the question of whether menopausal or contraceptive hormone treatments are more beneficial remains unanswered because no comparative studies have been conducted. The aim of this study was to summarise the main benefits and risks of menopausal hormone therapy for patients who have undergone haematopoietic stem cell transplantation.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Source Type: research